Risk and outcomes of COVID-19 in patients with multiple sclerosis.

ABSTRACT:

Background and purpose

Limited information is available on incidence and outcomes of COVID-19 in patients with multiple sclerosis (MS). This study investigated the risks of SARS-CoV-2 infection and COVID-19-related outcomes in patients with MS, and compared these with the general population.

Methods

A regional registry was created to collect data on incidence, hospitalization rates, intensive care unit admission, and death in patients with MS and COVID-19. National government outcomes and seroprevalence data were used for comparison. The study was conducted at 14 specialist MS treatment centers in Madrid, Spain, between February and May 2020.

Results

Two-hundred nineteen patients were included in the registry, 51 of whom were hospitalized with COVID-19. The mean age ±

SUBMITTER: Moreno-Torres I 

PROVIDER: S-EPMC8444942 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature